You are here

AstraZeneca in first Covid-19 vaccine deal with Chinese company

tl-astra-r-060820.jpg
Shenzhen Kangtai Biological Products will produce AstraZeneca's potential Covid-19 vaccine in mainland China, the British drugmaker said on Thursday, its first deal to supply one of the world's most populous countries.

[BEIJING] Shenzhen Kangtai Biological Products will produce AstraZeneca's potential Covid-19 vaccine in mainland China, the British drugmaker said on Thursday, its first deal to supply one of the world's most populous countries.

The deal underscores Astra's frontrunner position in a...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes